Last reviewed · How we verify

NCT04761315

Detecting Atrial Fibrillation in Patients With an Embolic Stroke of Undetermined Source (From the DAF-ESUS Registry)

Completed Last updated 18 February 2021
What this trial tests

trial in Fibrillation, Atrial in 380 participants. Completed in 31 December 2016.

Timeline
1 January 2015
Primary endpoint
31 December 2016
31 December 2016

Quick facts

Lead sponsorInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz
StatusCompleted
Study typeOBSERVATIONAL
Enrollment380
Start date1 January 2015
Primary completion31 December 2016
Estimated completion31 December 2016

Conditions studied

Sponsor

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz — full company profile →

Who can join

Adults 18 to 85, any sex, with Fibrillation, Atrial. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The presence of interatrial block (IAB) is associated with the development of atrial fibrillation (AF). The aim of this study was to determine whether P-wave duration and presence of IAB before the implantation of a cardiac implantable electronic device (CIED) are associated with the presence of atrial high rate episodes (AHRE), during long-term follow-up.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fibrillation, Atrial

Currently open trials in the same condition.

Other Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04761315.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing